St. Jude Research Hospital’s Giles Robinson has led a trial conducting research on a drug called entrectinib (Roche). The gene therapy shows promise in some of the most difficult pediatric tumors. The drug only targets a small subset of child cancers; however, patients whose tumors harbor the mutations targeted by the dug and have responded to treatment. Follow the link to Bloomberg to learn more about this Roche gene therapy study.

Source: Bloomberg

Pin It on Pinterest